This is the authors' abstract. We don't add key points for this paper.
Introduction Immunophenotyping improves accuracy of acute leukemia classification and is considered particularly useful for identifying aberrant lineage association of acute leukemia, biphenotypic and bilineal acute leukemia, as well as monitoring minimal residual disease [1]. The European Group for the Immunological Characterization of Acute Leukemia (EGIL) developed a scoring system that ranges from
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Elyamany et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: